ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.

AMPE Ampio Pharmaceuticals Inc

0.62
0.00 (0.00%)
21 Abr 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Ampio Pharmaceuticals Inc AMPE AMEX Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.00 0.00% 0.62 19:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
0.62 0.62
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
03/4/202413:33PRNUSAmpio Pharmaceuticals Received Audit Opinion with Going..
25/3/202416:00PRNUSAmpio Announces Voluntary Delisting and SEC Deregistration
04/3/202423:15EDGAR2Form EFFECT - Notice of Effectiveness
28/2/202414:49EDGAR2Form 8-K - Current report
28/2/202414:48EDGAR2Form S-8 POS - Securities to be offered to employees in..
28/2/202414:47EDGAR2Form S-8 POS - Securities to be offered to employees in..
28/2/202414:46EDGAR2Form POS AM - Post-Effective amendments for registration..
28/2/202414:45EDGAR2Form RW - Registration Withdrawal Request
15/2/202408:31EDGAR2Form 8-K - Current report
14/2/202416:45PRNUSAmpio Provides Update on Results from Pre-IND Enabling..
25/1/202415:31EDGAR2Form 8-K - Current report
25/1/202415:18EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
24/1/202416:16EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
11/1/202415:20EDGAR2Form 8-K - Current report
11/1/202415:15PRNUSAmpio Provides Litigation Update - Reports Settlement in..
21/12/202315:25EDGAR2Form S-1 - General form for registration of securities under..
14/11/202315:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/11/202308:30EDGAR2Form 8-K - Current report
31/10/202308:00PRNUSAmpio Pharmaceuticals to Present at the Emerging Growth..
27/10/202313:10EDGAR2Form 8-K - Current report
06/10/202313:56EDGAR2Form 8-K - Current report
05/10/202315:30PRNUSAmpio Selects Ascendia Pharmaceuticals, Inc. to Provide CDMO..
04/10/202315:15EDGAR2Form 8-K - Current report
26/9/202308:15PRNUSAmpio Pharmaceuticals to Present at the Emerging Growth..
22/9/202315:30EDGAR2Form 8-K - Current report
18/9/202315:30EDGAR2Form S-3 - Registration statement under Securities Act of..
31/8/202315:19EDGAR2Form 8-K - Current report
31/8/202305:30PRNUSAmpio Pharmaceuticals Announces Reverse Stock Split
15/8/202315:56EDGAR2Form S-8 - Securities to be offered to employees in employee..
08/8/202315:32EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/7/202310:33EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
05/7/202315:37EDGAR2Form 8-K - Current report
26/5/202315:40PRNUSAmpio Pharmaceuticals Announces Series D Preferred Stock..

Su Consulta Reciente

Delayed Upgrade Clock